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TS23Mechanical stimulation is important for the correct formation of the skeleton. Splotch-delayed mutant embryos
(Pax3Spd/Spd) that develop with no limbmuscle and therefore no limbmovement experience an alteredmechan-
ical environment resulting in speciﬁc defects in ossiﬁcation and joint formation, particularly in the forelimb. To
test the hypothesis that mechanical stimuli inﬂuence the regulation of genes important in skeletal development
we generated a transcriptome proﬁle of the developing humerus at Theiler stage 23 (TS23), and then identiﬁed
differentially expressed genes inmuscle-less mutant embryos compared to control littermates. Herewe describe
the experimental methods and analysis of the resulting data, publically available in the ArrayExpress database
under E-MTAB-1745 (Transcriptome of control humerus), E-MTAB-1744 (Microarray; differential expression)
and E-MTAB-1746 (RNA-sequencing; differential expression). Our data provide a resource for exploring the tran-
scriptome that underlies skeletal development at TS23 in themouse humerus. The interpretation and description
of this data can be found in a recent publication inBMCGenomics [1]. This is a resource for exploring themolecular
mechanisms that are involved in skeletal development and mechanotransduction.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).SpeciﬁcationsOrganism/cell line/tissue Mus musculus embryo, humerus, TS23
Strain C57BL/6 Pax3Spd/+, C57BL/6 Pax3Spd/SpdSequencer or array type Agilent Mouse GE v2 Microarrays (4x44K format)
Illumina GAII— RNA sequencingData format Raw and processed
Experimental factors Muscle-less mutant–v-control
Experimental features The purpose of this proﬁling analysis was to identify
differentially expressed genes between muscle-less
and control embryonic (TS23) humerus tissue, in
order to determine mechanosensitive genes that
impact skeletal development.Consent n/aDirect link to deposited data
Deposited data can be foundhere: http://www.ebi.ac.uk/arrayexpress/
experiments/E-MTAB-1744/ (Microarray; differential expression), http://
www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-1745/(TranscriptomeInc. This is an open access article uof control TS23 humerus) and http://www.ebi.ac.uk/arrayexpress/
experiments/E-MTAB-1746/ (RNA-sequencing; differential expression).Experimental design, materials and methods
Mouse model & RNA extraction
Heterozygous C57BL/Pax3Spd (Jackson Laboratory, Maine USA) mice
were time-mated to produce homozygous Pax3Spd/Spd mutant embryos
and littermate controls (Pax3Spd/+). All animal work was carried out
under the guidelines of the Trinity College Dublin Bioresources Unit
and Bioethics Committee. All embryonic material was harvested and
staged according to Theiler criteria [2] to obtain Theiler stage 23
(TS23), embryos at embryonic day 14.5 (E14.5). All the embryos were
genotyped [3] following PCR ampliﬁcation to conﬁrm homozygote
mutants and distinguish heterozygote and homozygote wildtype
littermates. The forelimb was ﬁnely micro-dissected from control and
mutant (Pax3Spd/Spd) embryos and the humerus and associated joints
removed. The humeri were pooled from multiple embryos of the same
genotype (2–4) totalling between 4–8 humeri for RNA extraction per
replicate. Tissue was mechanically homogenised using a motor operat-
ed pestle and mortar system in appropriate extraction buffer and totalnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Table 1
Details of samples used for microarray hybridization and RNA-sequencinga.
Source name Organism Part Developmental stage Genotype Experimental procedure RINb
RS-209_01 Control 1 Mus musculus Humerus Theiler stage 23 Splotch-delayed (Pax3Spd/+) Microarray & RNAseq 9.1
RS-211_08 Control 2 Mus musculus Humerus Theiler stage 23 Splotch-delayed (Pax3Spd/+) Microarray & RNAseq 9
RS-211_09 Control 3 Mus musculus Humerus Theiler stage 23 Splotch-delayed (Pax3Spd/+) Microarray 8.5
RS-211_10 Control 4 Mus musculus Humerus Theiler stage 23 Splotch-delayed (Pax3Spd/+) Microarray & RNAseq 8.1
RS-209_03 Mutant 1 Mus musculus Humerus Theiler stage 23 Splotch-delayed (Pax3Spd/Spd) Microarray & RNAseq 9.2
RS-211_04 Mutant 2 Mus musculus Humerus Theiler stage 23 Splotch-delayed (Pax3Spd/Spd) Microarray & RNAseq 8.4
RS-211_06 Mutant 3 Mus musculus Humerus Theiler stage 23 Splotch-delayed (Pax3Spd/Spd) Microarray & RNAseq 8.2
RS-211_07 Mutant 4 Mus musculus Humerus Theiler stage 23 Splotch-delayed (Pax3Spd/Spd) Microarray 9
a Source name as deﬁned in ArrayExpress database.
b RIN: RNA integrity number.
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quantity and integrity were assessed on a 2100 Bioanalyser (Agilent
Technologies). RNA samples with RNA integrity number (RIN) values
greater than 8 were used for microarray and RNA-sequencing analy-
sis. Details of the samples used for array hybridization and RNA-
sequencing as described in ArrayExpress are shown in Table 1.
Microarray study design
Four independent pooled sets of biological replicate samples were
used for microarray (n = 4 biological replicates) analysis, as shown in
Table 1. All microarrays were processed at IMGM® Laboratories
(Martinsried, Germany). The protocol involved the reverse transcrip-
tion of 100 ng of total RNA per sample into cDNA and then the conver-
sion into labelled cRNA by in vitro transcription (Low input quick-amp
labelling kit one-colour, Agilent Technologies) incorporating cyanine-
3-CTP. All cRNA was quality control checked to asses yield and activity
prior to hybridisation. The cRNA values ranged from 4.53 μg to 1.70 μg
and completely fulﬁlled the quality criteria deﬁned by Agilent. The
cRNA was cleaned up and quantiﬁed and 1.65 μg of each Cyanine-3-
labelled cRNA sample was fragmented and prepared for one-colour
based hybridisation (Gene Expression Hybridisation Kit, Agilent
Technologies). The cRNA samples were hybridised at 65 °C for 17 h on
separate Mouse GE v2 Microarrays (4x44K format) (G4846A, Agilent
Technologies), which contain 39,485 coding and non-coding sequences
of the mouse genome. Microarrays were then washed with increased
stringency using Gene Expression Wash Buffers (Agilent Technologies)
followed by drying with Acetonitrile (Sigma). Fluorescent signalTable 2
Details of protocols used for microarray hybridization and RNA-sequencing*.
Microarray Treatment protocol RNA extraction
protocol
Nucleic acid labelling
protocol
Muscleless phenotype,
spontaneous Spd/Spd
mutation (Jax labs)
Heterozygous matings to
generate TS23 embryos
SV Total RNA
Isolation system,
Promega, UK
RNA RT into cDNA and
converted into labelled
cRNA by IVT incorporating
cyanine-3-CTP
Muscleless phenotype,
spontaneous Spd/Spd
mutation (Jax labs)
Heterozygous matings to
generate TS23 embryos
SV Total RNA
Isolation system,
Promega, UK
RNA RT into cDNA and
converted into labelled
cRNA by IVT incorporating
cyanine-3-CTP
RNA-sequencing Nucleic acid library constru
protocol
RNA prepared into RNA-Se
libraries with the TruSeq
RNA Sample Prep kit.
RT: Reverse transcription, IVT: In vitro transcription, and DE: differential expression.intensities were detected with Scan Control A.8.4.1 software (Agilent
Technologies) in the Agilent DNA microarray scanner and extracted
from the images using Feature Extraction 10.7.3.1 software (Agilent
Technologies). A workﬂow of the individual protocol followed for
microarray preparation can be seen in Table 2.
RNA-sequencing alignment
A total of six independent DNase-treated RNA (3 μg) samples of the
control and mutant preparations, as indicated in Table 1, were used to
prepare RNA-sequencing libraries with the TruSeq RNA Sample Prep
kit for RNA-sequencing. Libraries were prepared according to the
Illumina protocol (Illumina Part #15008136 Rev. A) and sequenced on
an Illumina GAII sequencer (Trinity Genome Sequencing Laboratory,
Institute of Molecular Medicine, Trinity College Dublin, Ireland). The
workﬂow to prepare the libraries consisted of puriﬁcation and fragmen-
tation of the mRNA, ﬁrst strand cDNA synthesis, second strand cDNA
synthesis, repair of fragmented ends into blunt ends, adenylate 3′
ends, ligation of adapters, PCR ampliﬁcation and library validation. The
six constructed cDNA libraries represent triplicate biological replicates
for each group. 40 bp single end reads were obtained from an Illumina
GAII in FASTQ format, with one sample per sequencing lane (n = 6).
The Tophat aligner (http://tophat.cbcb.umd.edu/) was used to align
the reads to the mouse reference genome (mm9). After alignment the
read counts for each gene were extracted using htseq-count (http://
www-huber.embl.de/users/anders/HTSeq/) based on an mm9 Refseq
gff ﬁle. A workﬂow of the individual protocols followed for RNA-
sequencing preparation can be seen in Table 2.Nucleic acid hybridization
to array protocol
Array scanning protocol Normalisation of data
transformation tools used
Mouse GE v2
microarray platforms
(4x44K format)
Fluorescent signal
ntensities detected with
Scan Control A.8.4.1
Feature Extraction 10.7.3.1,
GeneSpring GX 11.5.1 and
Spotﬁre Decision Site 9.1.2
Mouse GE v2
microarray platforms
(4x44K format)
Fluorescent signal
intensities detected with
Scan Control A.8.4.1
Feature Extraction 10.7.3.1,
GeneSpring GX 11.5.1 and
Spotﬁre Decision Site 9.1.2
ction Nucleic acid sequencing
protocol
Normalisation of data
transformation tools used
q 40 bp single end reads
Illumina GAII in FASTQ
format
Tophat aligner aligned reads
to reference genome (mm9).
Read counts extracted using
htseq-count. DE evaluated
using DESeq version 1.4.1
Table 3
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The three constructed libraries of the TS23 control developing
humerus samples representing distinct biological replicates were se-
quenced using Illumina GAII and aligned to the mm9 mouse reference
genome. Following alignment, an average read count value was com-
puted from the three replicates and the total number of transcripts
with greater than/equal to 5 reads were deﬁned as expressed.
Differential expression quantiﬁcation
Microarray
The software tools Feature Extraction 10.7.3.1, GeneSpringGX 11.5.1
(both Agilent Technologies) and Spotﬁre Decision Site 9.1.2 (TIBCO)
were used for quality control and statistical data analysis. Quantile
normalisation was applied to each data set in order to impose the
same distribution of probe signal intensities for each array [4], thus
adjusting them to a uniform level that can allow for comparable
downstream analysis. Welch's approximate t-test (“unpaired unequal
variance”, parametric) was applied to compare the control and mutant
groups. A corrected p-value was calculated based on the algorithm of
Benjamini and Hochberg [5], based on control of the false discovery
rate (FDR). In each comparison, two groups were compared in a
pairwise manner. The extent and direction of differential expression
between the groups were determined by calculating a fold change
value. A fold change of ≥2 and FDR-adjusted p-value of ≤0.05 were
used as criteria to indicate differential expression (DE) between the
two groups. For example a fold change value of 2 indicates a two-fold
induction or up-regulation, and a fold change of−2 indicated a two-
fold repression or down-regulation. The fold change threshold signiﬁes
that probes are induced by a factor of 2 (equal to 100% increase in
averaged normalised signal) or repressed by the same factor (equal to
a decrease of the initial signal by 50%).
RNA-sequencing
Differential expression (DE) at a gene level in our two groups
(control and mutant) was evaluated using DESeq version 1.4.1, imple-
mented in R 2.14.1. DESeq uses a negative binomial distribution to
model genic read counts following normalisation based on size factors
and variance. As with the microarray data the extent and direction of
differential expression was determined by calculating a fold change
value. The read count for an expressed gene from the control sample
(n = 3) was directly compared to the read count from the mutant
(n = 3) in order to obtain the fold change value. Values ≥2 were
taken as an indication of induction or up-regulation of expression,
while values ≤0.5 were taken to indicate repression or down-
regulation of expression. The p-values presented are adjusted for
multiple-testing with the procedure of Benjamini and Hochberg tocontrol the type I error rate, and a cut off of p ≤ 0.05 was used as a
threshold to deﬁne differential expression (Table 3).
Discussion
The data described here catalogue the transcriptome of a developing
skeletal rudiment (humerus; TS23), as well as reveal differentially
expressed genes between humeri developing normally and humeri
with reduced mechanical stimulation(Table 3). These datasets have re-
cently been analysed and interpreted to reveal aspects of the molecular
mechanisms involved inmechanotransduction during skeletal develop-
ment [1]. Here we describe the publically available datasets in order to
facilitate future analyses and integrationwith other appropriate studies.
The normal transcriptome (E-MTAB-1745) provides a valuable resource
to help understand the processes that are occurring during
skeletogenesis at this stage of development when ossiﬁcation and
joint speciﬁcation is occurring. These data can be used in combination
with other genome wide databases and tools, for example EurExpress
(www.eurexpress.org) which examines the spatial expression patterns
of 18,000 coding genes and over 400 microRNAs in the whole mouse
embryo at the same developmental stage examined here, TS23 [6].
Combining these resources gives information on the quantitative and
spatial expression of individual genes providing the basis to explore reg-
ulatory networks active during the development of skeletal rudiments.
Differential expression was revealed by both Microarray (374) and
RNAseq (1037) approaches with RNAseq showing greater sensitivity
in this respect [1]. These datasets can now be mined and integrated
with the results of other experiments examining the impact of mechan-
ical stimuli on developing tissues (e.g.[7]) and cells (e.g. [8]), focusing
perhaps on speciﬁc pathways or genes. This holds the potential to reveal
highly informed and supported hypotheses to drive functional studies,
for example, asking if similar pathways and component genes are affect-
ed by mechanical stimuli in different biological contexts.
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